Zelig Eshhar (1941–2025): a tribute for a life for immunotherapy
Zelig Eshhar, PhD, Fellow of the Academy of Immuno-Oncology (FAIO), passed away on July 3, 2025, at the age of 84.
Authors
- Carl H. June (ORCID: https://orcid.org/0000-0003-0241-3557)
- Michael T. Lotze (ORCID: https://orcid.org/0000-0003-3988-5419)
- Marcela V. Maus (ORCID: https://orcid.org/0000-0002-7578-0393)
- Robbie G. Majzner (ORCID: https://orcid.org/0000-0001-6969-8011)
- James P. Allison (ORCID: https://orcid.org/0000-0001-8980-5697)
- Crystal L. Mackall (ORCID: https://orcid.org/0000-0001-6323-4304)
- Michel Sadelain (ORCID: https://orcid.org/0000-0002-9031-8025)
- Renier J. Brentjens (ORCID: https://orcid.org/0000-0002-3364-5388)
- Steven A. Rosenberg (ORCID: https://orcid.org/0000-0002-8939-8910)
- Hinrich Abken (ORCID: https://orcid.org/0000-0002-4302-3240)
- Eric L. Smith (ORCID: https://orcid.org/0000-0002-0296-7587)
Institutions
- Boston Children's Hospital (US)
- Roswell Park Comprehensive Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- Columbia University Irving Medical Center (US)
- Leibniz Association (DE)
- Massachusetts General Hospital (US)
- Parker Institute for Cancer Immunotherapy (US)
- Dana-Farber Cancer Institute (US)
- UPMC Hillman Cancer Center (US)
- Stanford Medicine (US)
- National Cancer Institute (US)
- Leibniz Institute for Immunotherapy
- Columbia University (US)
- University of Pennsylvania (US)
- Stanford University (US)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1136/jitc-2025-013161
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00